CDKN2A and pancreatic neoplasm: Molecular profiling analyses of the pancreatic tumour datasets have identified both distinct pancreatic cancer subtypes, and mutations of the genes, KRAS, TP53, SMAD4 and CDKN2A as potential drivers of pancreatic cancer14–18.